Pay in 4 interest-free payments of $7.07 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
As we have seen, semaglutide, a GLP-1 receptor agonist known for its efficacy in managing type 2 diabetes and obesity, may also impact hormonal balance, particularly in patients undergoing hormone replacement therapy (HRT)
Cynthia Maxwell MD, MBA, FRCSC, DABOM (Obesity Medicine), is the Medical Content Director of First Exposure, the Vice President, Medical Affairs & System Transformation and Lead Medical Executive at Womens College Hospital and Professor, Faculty of Medicine, Department of Obstetrics and Gynaecology and Division of Maternal Fetal Medicine at the University of Toronto
For med spa owners, this creates real growth opportunities, but only for those who are prepared
for 6 weeks to 6 years) lowered serum triglyceride concentrations by 0.25 mmol/L but had no substantial effect on total cholesterol, LDL-cholesterol, or HDL-cholesterol (114)
Are there any serious side effects of GLP-1 RAs
